Search Results 211-220 of 18161 for Lymphocytic leukemia
... lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study to Evaluate Olaparib and Temozolomide in Treating ...
... Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Jacksonville, FL. The purpose of this study is to determine the optimal biologic dose (OBD) and ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
... Lymphoblastic Leukemia (B-ALL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...
Accessed April 22, 2025. Chronic lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id= ...
Kenderian's laboratory is to identify mechanisms of resistance to immunotherapy in chronic lymphocytic leukemia and other hematological cancers. Allogeneic ...
The lymphatic system is made up of organs, glands, tubelike vessels and ... In mantle cell lymphoma, changes happen that turn the B lymphocytes into cancer cells.
... lymphoblastic leukemia (B-ALL), Burkitt lymphoma or leukemia, or B-lineage lymphoblastic lymphoma (B-LBL). Participation eligibility. Participant eligibility ...
Chronic leukemias (chronic lymphocytic leukemi; CLL, chronic myeloid leukemia; CML); Clinical drug development in multiple myeloma and Waldenstrom's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.